41.3.37: Chapter 38

Pharmacology for Nurses · LibreTexts

0%

Contents

    Text

    Size
    100%
    Theme
    Typeface
    Line length
    Spacing

    Read aloud

    How

    Speed: 1×
    Light up
    Highlight

    Symbols: Mulberry Symbols, © 2018–2026 Steve Lee, CC BY-SA 4.0 (licence, the set), the site's own copies.

    From LibreTexts, under CC BY 4.0, as the source states it; its equations are written in TeX, which the PDF shows typeset. This page at LibreTexts.

    41.3.37: Chapter 38

    Review Questions

    1. a. Gloves should be worn when handling this drug because it has the potential to cause cancer.
    2. b. Erythromycin is the only FDA-approved eye medication used for ophthalmia neonatorum and is given directly after birth.
    3. a. A “glaucoma suspect” has risk factors for glaucoma including elevated intraocular pressure, optic nerve damage, visual field deficit, or a strong family history of glaucoma.
    4. d. Infections, such as eye infections, that are anatomically close to the brain can result in complications such as a secondary infection like meningitis.
    5. c. Prostaglandin analogues cause hyperpigmentation of the eyelids and increase eyelash length and thickness.
    6. b. Travoprost is more effective in Black clients than non-Black clients.
    7. d. If the client does not apply pressure to the nasolacrimal area to reduce drainage of this beta-blocking ocular medication into the systemic circulation, a drop in heart rate can occur.
    8. d. A known effect of prolonged ocular corticosteroids is an increased occurrence of cataracts.
    9. a. Serious side effects of ocular antiviral medications include retinal detachment, which is manifested by floaters and flashes of light.
    10. a. Because the drug is nonselective, it can bind to and block both beta-1 and beta-2 adrenergic receptors. When it binds to beta-2 receptors, it results in a decrease in heart rate, thus masking the signs of tachycardia often seen with hypoglycemia.

    This page titled 41.3.37: Chapter 38 was last modified on Sun, 29 Dec 2024 08:23:55 GMT and is shared under a CC BY 4.0 license and was authored, remixed, and/or curated by OpenStax.